The purpose of this study is to determine the effectiveness of buccal misoprostol and comparing this with vaginal route of the same drug.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
400 microgram misoprostol given buccally three hours before dilation and curettage (PHARMACIA CORPORATION - Istanbul, serial number 022-00, a tablet contains 200 micrograms)
400 microgram misoprostol (MISOPROSTOL - PHARMACIA CORPORATION - Istanbul, serial number 022-00, a tablet contains 200 micrograms)
Iraqi Medical Specialization
Risafa, Baghdad Governorate, Iraq
To compare the efficacy of buccal administration to the more commonly vaginal route for preoperative cervical and priming in patients with first trimester surgical abortion. (Buccal Vs. Vaginal Misoprostol in the First Trimester Missed Abortion.)
Time frame: March 2007 to March 2008
The secondary objectives are to compare the side effects and acceptability by the subjects.
Time frame: March 2007 to March 2008
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.